blood glutathione decreases in chronic diseases Participation the Prevention of Cardiovascular Frontiers | Glutathione and neurodegenerative

She really likes the taste

Laryngoscope 115 , 22092212 (2005)

A long-range, recurrent neuronal network linking the emotion regions with the somatic motor cortex

Targeting connexins: possible game changer in managing neuropathic pain

Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn

Why this trial matters : First ADC to move into the 1L HER2+ metastatic setting Breaks a decade-long treatment paradigm in first-line breast cancer care Confirms ADCs as frontline platforms, not just late-line salvage therapies Roche Giredestrant Delivers the First Phase III Win for an Oral SERD in Early Breast Cancer Roches oral SERD giredestrant reduced the risk of invasive disease recurrence versus standard endocrine therapy in the Phase III lidERA trial in ER-positive, HER2-negative early breast cancer, marking the first major advance in adjuvant endocrine therapy in decades